Extracellular matrix composite materials, and manufacture and use thereof

• US 9,186,435 B2
• Filed: 03/06/2009
• Issued: 11/17/2015
• Est. Priority Date: 09/04/2003
• Status: Active Grant

• Current Assignee: Cook Biotech Incorporated (Cook Group Incorporated)
• Original Assignee: Cook Biotech Incorporated (Cook Group Incorporated)
• Inventors: Hiles, Michael C.
• Primary Examiner(s): LI, QIAN JANICE
• Application Number:
  US12/399,635
• Publication Number:
  US 20090204228A1
• Time in Patent Office: 2,447 Days
• Field of Search: 424/422, 424/484, 424/569, 424/572, 424/574
• US Class Current: 1/1
• CPC Class Codes: A61K 35/22 Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
• CPC Class Codes: A61K 35/37 Digestive system
• CPC Class Codes: A61K 35/44 Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
• CPC Class Codes: A61L 27/3629 Intestinal tissue, e.g. small intestinal submucosa
• CPC Class Codes: A61L 27/3633 Extracellular matrix [ECM]
• CPC Class Codes: A61L 27/3641 characterised by the site of application in the body materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60
• CPC Class Codes: A61L 27/3645 Connective tissue
• CPC Class Codes: A61L 27/3804 characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
• CPC Class Codes: A61L 27/48 with macromolecular fillers
• CPC Class Codes: C08L 89/00 Compositions of proteins; Compositions of derivatives thereof foodstuff preparations A23J3/00

Abstract

Described are preferred extracellular matrix composites including a first extracellular matrix material having a second extracellular matrix material deposited thereon. The preferred materials are made by culturing cells in contact with an extracellular matrix graft material in a fashion to cause the cells to biosynthesize and deposit extracellular matrix components on the material. The cells are then removed to provide the extracellular matrix composite material.

Claims

1. A medical graft material, comprising an extracellular matrix composite including a first naturally derived extracellular matrix material having a surface, and a second, biosynthetically-deposited extracellular matrix material on said surface, wherein the second extracellular matrix material is secreted by cells onto the first extracellular matrix material, wherein the second, biosynthetically-deposited extracellular matrix material is secreted by cells which are xenogenic to the first extracellular matrix material wherein the second extracellular matrix material contains extracellular matrix components that are exogenous with respect to the first extracellular matrix material, and wherein said medical graft material is free of living cells.

2. The medical graft material of claim 1, wherein said second extracellular matrix material comprises one or more fiber-forming proteins.

3. The medical graft material of claim 2, wherein the one or more fiber-forming proteins include collagen and/or elastin.

4. The medical graft material of claim 1, wherein said second extracellular matrix material comprises one or more adhesive proteins.

5. The medical graft material of claim 4, wherein said adhesive proteins comprise fibronectin and/or laminin.

6. The medical graft material of claim 1, wherein the first extracellular matrix material comprises submucosa.

7. The medical graft material of claim 6, wherein the submucosa is intestinal, urinary bladder or stomach submucosa.

8. The medical graft material of claim 7, wherein the submucosa is small intestinal submucosa.

9. The medical graft material of claim 1, wherein the first extracellular matrix material is from a warm-blooded vertebrate.

10. The medical graft material of claim 1, wherein the second extracellular matrix material is human.

11. The medical graft material of claim 1, wherein the second extracellular matrix material is secreted by one or more of endothelial cells, muscle cells, fibroblast cells, mesothelial cells, pericyte cells, macrophage cells, monocyte cells, plasma cells, mast cells, adipocyte cells, chondrocyte cells, stem cells, or a cell population differentiated from stem cells.

12. The medical graft material of claim 11, wherein the second extracellular matrix material contains matrix components secreted by endothelial cells.

13. The medical graft material of claim 12, wherein the endothelial cells are vascular endothelial cells.

14. The medical graft material of claim 13 which is configured for implantation in the cardiovascular system of a human.

15. The medical graft material of claim 14, which has a tubular form, and wherein at least a lumenal surface of the tubular form contains said second extracellular matrix material.

16. An extracellular matrix graft prosthesis conditioned with matrix components, comprising:

an extracellular matrix graft material; and

biosynthetically-deposited exogenous extracellular matrix components on said extracellular matrix graft material, wherein the exogenous extracellular matrix components are secreted by cells onto the extracellular matrix graft material, and wherein said graft prosthesis is free of living cells and in a dried condition, and wherein said medical graft prosthesis is packaged in a sterile sealed package.

17. A graft prosthesis of claim 16, wherein said extracellular matrix graft material comprises a submucosa, dura mater, pericardium, serosa, peritoneum, or basement membrane matrix material.

18. A graft prosthesis of claim 17, wherein said extracellular matrix graft material comprises submucosa.

19. A graft prosthesis of claim 18, wherein said submucosa is mammalian submucosa.

20. A graft prosthesis of claim 19, wherein said mammalian submucosa is porcine, bovine, or ovine submucosa.

21. A graft prosthesis of claim 20, wherein said submucosa is porcine submucosa.

22. A graft prosthesis according to claim 16, wherein said matrix components include one or more members selected from the group consisting of collagen, elastin, fibronectin, and laminin.

23. A graft prosthesis according to claim 16, wherein said prosthesis has a tubular form, and said matrix components are on at least a lumenal surface of said tubular form.

24. A graft prosthesis according to claim 16, wherein said prosthesis has a sheet form, and wherein said matrix components are deposited on a surface of at least a first side of said sheet form.

25. A graft prosthesis according to claim 16, wherein said prosthesis has multiple layers, including at least one layer of said extracellular matrix graft material.

26. A graft prosthesis according to claim 25, wherein said prosthesis has multiple layers of said extracellular matrix graft material.

27. A graft prosthesis according to claim 16, wherein said matrix components are human.

28. The extracellular matrix graft prosthesis of claim 16, wherein the extracellular matrix graft material is non-human and the extracellular matrix components are human.